An investigational, inhaled antibiotic medication (Cipro) for Cystic Fibrosis is being studied here in Orlando by Global Clinical Research Management, Inc.
 

The primary purpose of this study is to evaluate the effectiveness of an investigational inhaled antibiotic for cystic fibrosis. 

 

 A potential candidate for this study is:

·         A child (12 – 17 years) or adult (18 years or older),  AND

·         Have been diagnosed with cystic fibrosis, AND

·         Have previously had a sputum culture show evidence of P. aeruginosa colonization.

 

If you choose to join the study, your participation will last up to 92 days.  During this time, you will visit our office on approximately 8 occasions where you will undergo various assessments and receive study-related physical examinations.

 

Study participants will also receive, at no charge, study related:

·         Medical care

·         Laboratory work and evaluations

·         Investigational medication or placebo (a capsule that looks like the investigational medication but contains no active medicine)

 

Financial compensation for time and travel may also be provided.

 

As with all investigational medications, there are potential risks which we will discuss fully with you and your family ahead of time.

 

How can you join the study?

To find out more about this research study and learn if you pre-qualify to participate, please call our office at

 

Matty Culbreth-Notaro, CCRC
Director of Biomedical Research
Global Clinical Research Management, Inc.
1009 Maitland Center Commons Blvd. # 212
Maitland, Fl. 32751
(o) 407-786-9715 ext. 122
(f) 866-401-9237
(c) 407-221-7398